| Dec'19 | Sep'19 | Jun'19 | Dec'18 | Sep'18 | Jun'18 | |
|---|---|---|---|---|---|---|
Operating expenses | ||||||
General and administrative | ||||||
1,115 | 1,138 | 251 | 126 | 31 | 31 | |
Accretion Expense | ||||||
-1,191 | 48,363 | - | - | - | - | |
Total operating expenses | ||||||
-76 | 49,501 | 251 | 126 | 31 | 31 | |
Operating income (loss) | ||||||
76 | -49,501 | -251 | -126 | -31 | -31 | |
Non-operating (income) expense | ||||||
Loss from Equity Method Investment in the Joint Venture | ||||||
-8,764 | -56,179 | -39,554 | -17,468 | -25,571 | -22,766 | |
(Gain) Loss on Sale of Interests in the Joint Venture | ||||||
- | - | - | 0 | 197 | 464 | |
Management fee income | ||||||
771 | 772 | 104 | 126 | 31 | 31 | |
Interest expense | ||||||
602 | 644 | - | - | - | - | |
Interest income | ||||||
601 | 644 | - | - | - | - | |
Amortization of debt discount and issuance costs | ||||||
191 | 212 | - | - | - | - | |
Unrealized (gain) loss on forward purchase contract | ||||||
74,084 | -2,435 | - | - | - | - | |
Total non-operating (income) expense | ||||||
65,899 | -58,054 | -39,450 | -17,342 | -25,343 | -22,271 | |
Income (loss) before income tax provision (benefit) | ||||||
65,975 | -107,555 | -39,701 | -17,468 | -25,374 | -22,302 | |
Income tax provision (benefit) | ||||||
15,240 | -13,620 | -2,184 | -5,080 | -6,783 | -4,801 | |
Net income (loss) | ||||||
50,735 | -93,935 | -37,517 | -12,388 | -18,591 | -17,501 | |
Net income (loss) per share: | ||||||
Basic | ||||||
0.35 | -0.66 | -0.50 | -0.16 | -0.25 | -0.23 | |
Diluted | ||||||
0.35 | -0.66 | -0.50 | -0.16 | -0.25 | -0.23 | |
Weighted average shares (see Note 5): | ||||||
Basic | ||||||
143,392 | 142,223 | 75,474 | 75,465 | 75,506 | 75,604 | |
Diluted | ||||||
146,201 | 142,223 | 75,474 | 75,465 | 75,506 | 75,604 | |